Myeloid malignancies like AML, MDS, and CML generally showed higher TGFB1 expression when compared to normal samples and the opposite was seen in lymphoid leukemias (ALL and CLL) (Fig. 2A). This evidence concerns the gene TGFB1 and lymphoid leukemia.